✦ LIBER ✦

Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma

✍ Scribed by Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Tetsuya Toge

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 224 KB
Volume: 101
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20636

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic potential of antisense Bcl-2

Therapeutic potential of antisense Bcl-2 as a chemosensitizer for cancer therapy

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Evaluation of cell proliferation, epider

Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with world health organization grade 2 oligodendroglioma

✍ Jorge S. Reis-Filho; Leonardo N. Faoro; Carla Carrilho; Luiz F. Bleggi-Torres; F 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## BACKGROUND. Prognostic factors in oligodendrogliomas are an area of controversy in neuropathology. Although grading and the study of some morphologic variables may be of value as prognostic parameters, the variability of postoperative disease free survival in patients with World Health Organizat

A multicenter evaluation of intensified,

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma

✍ Francis Lévi; Rachid Zidani; Silvano Brienza; Luigi Dogliotti; Bruno Perpoint; M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## BACKGROUND. The combination of 5-fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (l-OHP) was shown to be both more active against metastatic colorectal carcinoma and better tolerated if the drug delivery rate was chronomodulated according to circadian rhythms rather than constant. This all

Soluble interleukin-2 receptor serum lev

Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma : Results of a multivariate prospective study

✍ Eric Tartour; Laurent Deneux; Veronique Mosseri; Christian Jaulerry; Françoise B 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

Jose ´Rodriguez, M.D. ## RESULTS. At presentation, a relationship was observed between advanced tumor (T) classification and high serum levels of CRP (P Å 0.0015) and s-IL-2-R (P õ Head and

Serum insulin-like growth factor I evalu

Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis : A prospective study

✍ Gherardo Mazziotti; Francesca Sorvillo; Filomena Morisco; Antonella Carbone; Mar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 3 views

## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first